Open access
Open access
Powered by Google Translator Translator

Cardiology

M-A: Hypothermic vs. normothermic temperature control after cardiac arrest.

24 Jun, 2022 | 11:51h | UTC

Hypothermic versus Normothermic Temperature Control after Cardiac Arrest – NEJM Evidence

Related:

ERC-ESICM guidelines on temperature control after cardiac arrest in adults – Intensive Care Medicine (if the link is paywalled, try this one)

Target temperature management following cardiac arrest: a systematic review and Bayesian meta-analysis – Critical Care

Targeted temperature management following out-of-hospital cardiac arrest: a systematic review and network meta-analysis of temperature targets – Intensive Care Medicine

Targeted Temperature Management for Cardiac Arrest Due to Non-shockable Rhythm: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Frontiers in Medicine

Effect of Moderate vs Mild Therapeutic Hypothermia on Mortality and Neurologic Outcomes in Comatose Survivors of Out-of-Hospital Cardiac Arrest: The CAPITAL CHILL Randomized Clinical Trial – JAMA

Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest – New England Journal of Medicine

 


An update on refractory hypertension.

24 Jun, 2022 | 11:44h | UTC

An Update on Refractory Hypertension – Current Hypertension Reports

 


AHA Scientific Statement: Cardiopulmonary consequences of vaping in adolescents.

23 Jun, 2022 | 13:03h | UTC

Cardiopulmonary Consequences of Vaping in Adolescents: A Scientific Statement From the American Heart Association – Circulation Research

News Release: Action needed to reduce e-cigarette use among adolescents to lower lifetime CVD risk – American Heart Association

 


RCT: Effectiveness and safety of early initiation of poststernotomy cardiac rehabilitation exercise training.

23 Jun, 2022 | 12:59h | UTC

Effectiveness and Safety of Early Initiation of Poststernotomy Cardiac Rehabilitation Exercise Training: The SCAR Randomized Clinical Trial – JAMA Cardiology (free for a limited period)

 

Commentary on Twitter

 


RCT: Effect of MRI-guided fibrosis ablation vs. conventional catheter ablation on atrial arrhythmia recurrence in patients with persistent atrial fibrillation.

23 Jun, 2022 | 12:57h | UTC

Effect of MRI-Guided Fibrosis Ablation vs Conventional Catheter Ablation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The DECAAF II Randomized Clinical Trial – JAMA (free for a limited period)

News Release: Global AFib study finds simple approach is best for ablation procedures – Tulane University

 

Commentary on Twitter

 


M-A: Early versus delayed complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel disease.

23 Jun, 2022 | 10:11h | UTC

Early versus delayed complete revascularisation in patients presenting with ST-segment elevation myocardial infarction and multivessel disease: a systematic review and meta-analysis of randomised controlled trials – openheart

 


USPSTF Statement: The current evidence is insufficient to recommend vitamins for the prevention of cardiovascular disease or cancer.

22 Jun, 2022 | 12:21h | UTC

Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement – JAMA

Evidence Report and Systematic Review: Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer – JAMA

Patient Page: Vitamins and Minerals to Prevent Cardiovascular Disease and Cancer – JAMA

Editorial: Why Too Many Vitamins Feels Just About Right – JAMA Internal Medicine

Author Interview: Why Too Many Vitamins Feels Just About Right – JAMA

Commentary: Vitamins, Supplements Useless for Most People: Expert Panel – HealthDay

 


Cohort Study: Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA.

22 Jun, 2022 | 12:07h | UTC

Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases – The Lancet

Commentaries:

COVID-19 mRNA vaccination and myocarditis or pericarditis – The Lancet

Myocarditis and Pericarditis After the COVID-19 mRNA Vaccination – American College of Cardiology

Related:

SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents – JAMA Cardiology

Myocarditis and pericarditis after COVID-19 vaccination: clinical management guidance for healthcare professionals – UK Health Security Agency

Myocarditis following a third Pfizer vaccination dose in military recruits in Israel.

Myocarditis following COVID-19 BNT162b2 vaccination among adolescents in Hong Kong.

[Preprint] Post-marketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12-39 years in Italy.

Myocarditis after BNT162b2 vaccination in Israeli adolescents.

Myocarditis cases reported after mRNA-Based COVID-19 vaccination in the US from December 2020 to August 2021.

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

[Preprint] Risk of myocarditis following sequential COVID-19 vaccinations by age and sex.

Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination vs. SARS-CoV-2 infection.

Case series with 139 adolescents and young adults with suspected myocarditis following mRNA vaccination showed most cases had a mild clinical course and rapid resolution of symptoms.

Heart-inflammation risk from Pfizer COVID vaccine is very low.

Large cohort study with over 2.5 million individuals showed the incidence of myocarditis after the Pfizer vaccine was 2.13 cases per 100,000 persons.

Study with over 5.1 million vaccinated individuals showed the incidence of myocarditis after the receipt of the Pfizer vaccine was low and more common after the second dose in young male recipients.

Large Observational study shows Pfizer Covid vaccine is mostly safe but is associated with increased risk of myocarditis, adenopathy, appendicitis, and herpes zoster.

 


Guidelines for the use of cardiac magnetic resonance in pediatric congenital and acquired heart disease.

22 Jun, 2022 | 11:31h | UTC

Society for Cardiovascular Magnetic Resonance/European Society of Cardiovascular Imaging/American Society of Echocardiography/Society for Pediatric Radiology/North American Society for Cardiovascular Imaging Guidelines for the Use of Cardiac Magnetic Resonance in Pediatric Congenital and Acquired Heart Disease: Endorsed by The American Heart Association – Circulation: Cardiovascular Imaging

 


Cohort Study: Association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease.

22 Jun, 2022 | 11:18h | UTC

The association between short-term, chronic localized and chronic widespread pain and risk for cardiovascular disease in the UK Biobank – European Journal of Preventive Cardiology

 


Cardiovascular disease in primary Sjögren’s syndrome: raising clinicians’ awareness.

22 Jun, 2022 | 10:55h | UTC

Cardiovascular Disease in Primary Sjögren’s Syndrome: Raising Clinicians’ Awareness – Frontiers in Immunology

 


Cohort Study: Cardiometabolic multimorbidity, genetic risk, and dementia.

21 Jun, 2022 | 11:01h | UTC

Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study – The Lancet Health Longevity

News Release: Multiple heart-related conditions linked to triple dementia risk regardless of genetics – University of Oxford

Related:

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression – Alzheimer’s & Dementia

Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia – Neurology

Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology

Preventing dementia: what’s the evidence? – Evidently Cochrane

 


Cohort Study: Cardiometabolic multimorbidity linked to accelerated cognitive decline and dementia progression.

21 Jun, 2022 | 10:59h | UTC

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression – Alzheimer’s & Dementia

News Release: Diabetes and cardiovascular disease increase dementia risk – Karolinska Institutet

Related:

Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study – The Lancet Health Longevity

Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia – Neurology

Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology

Preventing dementia: what’s the evidence? – Evidently Cochrane

 


Cohort Study: Association of cardiovascular risk trajectory with cognitive decline and incident dementia.

21 Jun, 2022 | 10:58h | UTC

Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia – Neurology

Commentary: Heart Risk Factors Can Be Recipe for Dementia – HealthDay

Related:

Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study – The Lancet Health Longevity

Cardiometabolic multimorbidity accelerates cognitive decline and dementia progression – Alzheimer’s & Dementia

Genetic Risk, Midlife Life’s Simple 7, and Incident Dementia in the Atherosclerosis Risk in Communities Study – Neurology (link to abstract – $ for full-text) AND Commentary: Seven healthy habits linked to lower risk of dementia in those with genetic risk – American Academy of Neurology

Preventing dementia: what’s the evidence? – Evidently Cochrane

 

Commentary on Twitter

 


M-A: Comparison of bifurcation techniques for percutaneous coronary intervention.

21 Jun, 2022 | 10:50h | UTC

Systematic Review and Network Meta‐Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention – Journal of the American Heart Association

 


Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study.

21 Jun, 2022 | 10:44h | UTC

Safety of bariatric surgery in patients with previous acute coronary events or heart failure: nationwide cohort study – BJS Open

 

Commentary on Twitter

 


Cohort Study: Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes.

20 Jun, 2022 | 10:36h | UTC

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank – eClinicalMedicine

 

Commentary on Twitter

Under a CC BY-NC-ND 4.0 license

 


Review, Statements, and Recommendations: Cuffless blood pressure measuring devices.

20 Jun, 2022 | 01:26h | UTC

Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

Related:

Guidance for the Interpretation of Continual Cuffless Blood Pressure Data for the Diagnosis and Management of Hypertension – Frontiers in Medical Technology

Wearable Cuffless Blood Pressure Monitoring Devices: A Systematic Review and Meta-Analysis – European Heart Journal – Digital Health

 


Perspective | Cardiovascular meta-analyses: fool’s gold or gold for fools?

20 Jun, 2022 | 01:15h | UTC

Cardiovascular meta-analyses: fool’s gold or gold for fools? – European Heart Journal

 


Prospective head-to-head comparative study: Functional stress imaging to predict abnormal coronary fractional flow reserve.

20 Jun, 2022 | 01:10h | UTC

Functional stress imaging to predict abnormal coronary fractional flow reserve: the PACIFIC 2 study – European Heart Journal

Editorial: Stress imaging versus fractional flow reserve: what comes first—the chicken or the egg? – European Heart Journal

 

Commentary on Twitter

Under a https://creativecommons.org/licenses/by-nc/4.0/ license

 


M-A: Heat exposure and cardiovascular health outcomes.

20 Jun, 2022 | 01:00h | UTC

Heat exposure and cardiovascular health outcomes: a systematic review and meta-analysis – The Lancet Planetary Health

 

Commentary on Twitter (thread – click for more)

 


Cardiac xenotransplantation: challenges, evolution, and advances.

20 Jun, 2022 | 00:58h | UTC

Cardiac Xenotransplantation: Challenges, Evolution, and Advances – JACC: Basic to Translational Science

News Release: New review paper proposes framework for advancing application of animal-to-human transplantation – American College of Cardiology

Commentary: Many Hurdles to Clear Before Cardiac Xenotransplantation Takes Off – TCTMD

Related:

In 1st, US surgeons transplant pig heart into human patient – Associated Press

Results of Two Cases of Pig-to-Human Kidney Xenotransplantation – New England Journal of Medicine (link to abstract – $ for full-text)

Moving xenotransplantation research into human trials will require adjusting our expectations, researchers say – STAT

After a flurry of firsts, xenotransplantation is suddenly back in the spotlight – STAT

 


AHA Scientific Statement: Revascularization for renovascular disease.

17 Jun, 2022 | 11:50h | UTC

Revascularization for Renovascular Disease: A Scientific Statement From the American Heart Association – Hypertension

Top Things to Know: Revascularization for Renovascular Disease – American Heart Association

Commentary: When is Renovascular Hypertension Amenable to Revascularization – American Heart Association

 


Post Hoc Secondary Analysis of RCT: Rivaroxaban monotherapy is associated with better outcomes vs. combination therapy with antiplatelets in patients with atrial fibrillation and stable coronary artery disease.

17 Jun, 2022 | 11:07h | UTC

Rivaroxaban Monotherapy vs Combination Therapy With Antiplatelets on Total Thrombotic and Bleeding Events in Atrial Fibrillation With Stable Coronary Artery Disease: A Post Hoc Secondary Analysis of the AFIRE Trial – JAMA Cardiology (free for a limited period)

Commentaries:

Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Disease: Does Less Mean More? – JAMA Cardiology (free for a limited period)

Rivaroxaban Mono vs. Combo Therapy for Thrombotic and Bleeding Events in AF – American College of Cardiology

Rivaroxaban Monotherapy Linked to Lower Event Risk in Patients with AF, Stable CAD – HCPLive

 

Commentary on Twitter

 


Cohort Study: Association of sitting time with mortality and cardiovascular events in high-income, middle-income, and low-income countries.

17 Jun, 2022 | 11:05h | UTC

Association of Sitting Time With Mortality and Cardiovascular Events in High-Income, Middle-Income, and Low-Income Countries – JAMA Cardiology (free for a limited period)

Commentary: Trade the chair for fresh air: Sitting time and cardio health – Simon Fraser University

 

Commentary from one of the authors on Twitter

 


Stay Updated in Your Specialty

No spam, just news.